Black Friday saleUp to 70% OFF
DIREXION SHARES ETF TRUSTDIREXION SHARES ETF TRUSTDIREXION SHARES ETF TRUST

DIREXION SHARES ETF TRUST

No trades
See on Supercharts
Overview Analysis News
Ideas
Discussions Seasonals

LABU trade ideas

Build Positions in BiotechAs the month of October begins and broader markets sold off, Biotech sectors are still negative/ flat for the year. Market headlines from high prescription drug prices and lawsuits regarding the opioid epidemic have plagued some of the IBB's largest holdings; which have held biotech ETF's down while the S&P reached all time highs. Fast-Track Synopsis: Biotech is a known high volatility trading environment; More Investors will become "Traders" with new $0 trading fee platforms from Schwab and TD Ameritrade. Once people begin trading stocks, they will find that high volatility is how the "big" day-trade/ swing trading money is made. New Med-tech and Biotechnology therapies (i.e. gene therapies, NASH/ NAFLD) are ripening and getting closer to approval. There are currently over 240 biotechnology companies with Gene therapy IP IP has been growing with RMAT and Breakthrough Designations due to unmet need of new novel treatments; As Biotech rolls into year-end, lower interest rates will propel company growth models which I believe will help drive buy outs. LABU Technical Analysis: Bullish Harmonic Gartley pattern and close to 52-week low. 1-year Gartley pattern should move LABU stock price back up to around $40 level (resistance) where we will be watching for a potential breakout CCI measured "oversold" with the end of September pullback, CCI-slope is now trending higher, This last pullback also measures a double bottom (data points are from Christmas 2018 and present) Intra-day bullish RSI divergence, Daily RSI trending higher; the MS Signal recently flipped green as of 10/1/2019 and is still indicating a nice swing opportunity to come. Three-drives pattern bouncing toward resistance concurrent with double bottom and Gartley pattern. Look for the support level (marked (x)) to hold. See conclusion here ! Please like and follow so we can continue finding awesome charts/ trades. For more pre-researched Biotech trade-ideas click and visit us at MS Money Moves . Thanks in advance everyone!! Disclosure: I do not own LABU, I may buy or sell within the next 48 hours. This is not a recommendation to buy or sell. Please do your homework before investing.
AMEX:LABULong
by follow_the_money
2
LABU - watch the volume and trend lineBiotech has had a hard time of it lately due to both political risks related to the election and litigation risks from the opioid epidemic. All of this, of course, on top of broad market weakness due to the China trade war. However, biotech earnings are better than most sectors this season, so the bear market likely won't continue forever. I've drawn a trend line on my 1-hour chart and am watching for an upward breakout. Today we had some nice volume come in as we recovered from oversold on the daily chart and achieved our first green day for some time. However, we fell short of the minimum 6 million shares I'd like to see to signify a true reversal. We also fell short of breaking my trend line. I expect LABU will fall to about 25.50 before it's likely to get a real bounce.
AMEX:LABULong
by ChristopherCarrollSmith
Pharmaceuticals showing strength this earnings seasonIt's been a banner quarter for large-cap pharmaceutical companies. We've had earnings beats and guidance upgrades from GlaxoSmithKline, Biogen, Bristol-Myers Squibb, Merck, Celgene, and Procter & Gamble. More earnings beats may be coming, with Amgen reporting today after market and Amarin tomorrow. In my opinion, the whole sector is set to surge, and the leveraged Direxion Biotech Bull ETF could be a very strong play this quarter if you can find a good entry point.
AMEX:LABULong
by ChristopherCarrollSmith
My fans asked and I obliged, but LABU ain't lookin' greatOne of my followers asked (and this has never happened before) for me to comment on LABU. I was touched by the request and so I have responded, and this after having a website which I shut down with 10,000 hits a month never once did anyone ask me to comment on a stock. My strength has always been analysis and dissection so I am happy to oblige. LABU isn't looking very strong. Its currently trending downwards, it's below the SMA line which I used for my day trades and it has a lot of overhead resistance. For a while it looked like it was in a condensing pattern and has broken down and then decided to move sideways. These are not adjectives and verbs you use to describe a stock that's in a good place. The odd thing, going to about two years is that the stock is inside an even larger condensing pattern that must be watched closely. Its currrently holding just above support and if this breaks a big slide could be witnessed!
AMEX:LABUShort
by DanjaZown
2